Tarsus Pharmaceuticals (TARS) EBITDA (2019 - 2026)
Tarsus Pharmaceuticals' EBITDA came in at -$660.92 million for Q3 2026, compared with -$13.98 million a year earlier.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) EBITDA (2019 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Tarsus Pharmaceuticals reported EBITDA of -$692.53 million; for FY2025, it was -$68.48 million.
- Going back by year, EBITDA was -$118.85 million in FY2024, -$141.9 million in FY2023, -$62.08 million in FY2022 and -$11.85 million in FY2021.
- The Q3 2026 figure represents the lowest quarterly EBITDA in data going back to Q3 2019.
- Business Quant data shows TARS's EBITDA at -$18.74 million (Q2 2026), -$5.52 million (Q1 2026) and -$7.34 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Tarsus Pharmaceuticals | 3.35 Bn | 2.41 Bn | 180.68 Mn | -660.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -660.92 Mn |
| Jun 30, 2026 | -18.74 Mn |
| Mar 31, 2026 | -5.52 Mn |
| Dec 31, 2025 | -7.34 Mn |
| Sep 30, 2025 | -13.98 Mn |
| Jun 30, 2025 | -21.64 Mn |
| Mar 31, 2025 | -25.68 Mn |
| Dec 31, 2024 | -23.84 Mn |
| Sep 30, 2024 | -24.73 Mn |
| Jun 30, 2024 | -33.00 Mn |
| Mar 31, 2024 | -37.27 Mn |
| Dec 31, 2023 | -44.00 Mn |
| Sep 30, 2023 | -40.70 Mn |
| Jun 30, 2023 | -32.61 Mn |
| Mar 31, 2023 | -24.77 Mn |
| Dec 31, 2022 | -14.89 Mn |
| Sep 30, 2022 | -22.77 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Mar 31, 2022 | -19.43 Mn |
| Dec 31, 2021 | -14.41 Mn |
API Access
Tarsus Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();